Still on a laboratory scale, the technology developed by the Unicamp Chemistry Institute holds promise for reducing side effects caused by oncology treatments. The patent was filed by the university with the INPI (National Institute of Industrial Property) and will be presented by the partnerships team of the Innovation Agency Inova Unicamp during the Pharma Meeting Brazil 2017, which will be held on May 26th, in São Paulo, with the objective of presenting business opportunities for pharmaceutical and healthcare companies.
More on the Inova Unicamp Innovation Agency page